Cargando…

Mindfulness-Based Stress Reduction Therapy Improves Patient and Caregiver-Reported Outcomes in Cirrhosis

OBJECTIVES: Patient-reported outcomes such as health-related quality of life (HRQOL) are impaired in cirrhosis due to under-treated mood and sleep disorders, which can adversely impact their caregivers. Mindfulness-based stress reduction (MBSR) can improve patient-reported outcomes (PRO) in non-cirr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bajaj, Jasmohan S, Ellwood, Michael, Ainger, Timothy, Burroughs, Thomas, Fagan, Andrew, Gavis, Edith A, Heuman, Douglas M, Fuchs, Michael, John, Binu, Wade, James B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Original Contributions
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5539344/ https://www.ncbi.nlm.nih.gov/pubmed/28749453 http://dx.doi.org/10.1038/ctg.2017.38

Ejemplares similares

Serum and urinary metabolomics and outcomes in cirrhosis
por: Bajaj, Jasmohan S., et al.
Publicado: (2019)

Fecal Microbiota Transplant in Cirrhosis Reduces Gut Microbial Antibiotic Resistance Genes: Analysis of Two Trials
por: Bajaj, Jasmohan S., et al.
Publicado: (2020)

Distinct gut microbial compositional and functional changes associated with impaired inhibitory control in patients with cirrhosis
por: Bajaj, Jasmohan S, et al.
Publicado: (2021)

Perspectives of Inpatients With Cirrhosis and Caregivers on Using Health Information Technology: Cross-sectional Multicenter Study
por: Acharya, Chathur, et al.
Publicado: (2021)

Gut Microbiota Alterations can predict Hospitalizations in Cirrhosis Independent of Diabetes Mellitus
por: Bajaj, Jasmohan S., et al.
Publicado: (2015)

Erratum: Gut Microbiota Alterations can predict Hospitalizations in Cirrhosis Independent of Diabetes Mellitus
por: Bajaj, Jasmohan S., et al.
Publicado: (2016)

Multiple bacterial virulence factors focused on adherence and biofilm formation associate with outcomes in cirrhosis
por: Bajaj, Jasmohan S, et al.
Publicado: (2021)

Impaired Gut-Liver-Brain Axis in Patients with Cirrhosis
por: Ahluwalia, Vishwadeep, et al.
Publicado: (2016)

A specialized HE testing clinic improves rational decision-making for therapy in cirrhosis
por: Nadeem, Mahum, et al.
Publicado: (2023)

Gut Microbiota as Biosensors in Patients With Cirrhosis
por: Bajaj, Jasmohan S.
Publicado: (2019)

Subjective and objective burden on providers from a multicenter app-based study of patients with cirrhosis and caregivers
por: Shaw, Jawaid, et al.
Publicado: (2023)

Modulation of the Metabiome by Rifaximin in Patients with Cirrhosis and Minimal Hepatic Encephalopathy
por: Bajaj, Jasmohan S., et al.
Publicado: (2013)

Elderly patients have an altered gut-brain axis regardless of the presence of cirrhosis
por: Bajaj, Jasmohan S., et al.
Publicado: (2016)

Whoop there it is: decoding sleep, cirrhosis, and HE
por: Badal, Bryan D., et al.
Publicado: (2023)

Impact of Hepatic Encephalopathy in Cirrhosis on Quality-of-Life Issues
por: Montagnese, Sara, et al.
Publicado: (2019)

Substance‐use simulation impairs driving capability in patients with cirrhosis regardless of hepatic encephalopathy
por: Acharya, Chathur, et al.
Publicado: (2022)

Area Deprivation Index and Gut-Brain Axis in Cirrhosis
por: Bajaj, Jasmohan S., et al.
Publicado: (2022)

Rifaximin Exerts Beneficial Effects Independent of its Ability to Alter Microbiota Composition
por: Kang, Dae J, et al.
Publicado: (2016)

Effect of Increasing Age on Brain Dysfunction in Cirrhosis
por: Liu, Runping, et al.
Publicado: (2018)

Sa1372: TRACKING CIRRHOSIS CARE DURING COVID-19 PANDEMIC
por: Adejumo, Adeyinka C., et al.
Publicado: (2022)

Cirrhosis, bile acids and gut microbiota: Unraveling a complex relationship
por: Ridlon, Jason M, et al.
Publicado: (2013)

Variability and Lability of Ammonia Levels in Healthy Volunteers and Patients With Cirrhosis: Implications for Trial Design and Clinical Practice
por: Bajaj, Jasmohan S., et al.
Publicado: (2019)

Cost-Effectiveness of Risk Score–Stratified Hepatocellular Carcinoma Screening in Patients with Cirrhosis
por: Goossens, Nicolas, et al.
Publicado: (2017)

Deprescribing medications that may increase the risk of hepatic encephalopathy: A qualitative study of patients with cirrhosis and their doctors
por: Williams, Sydni, et al.
Publicado: (2021)

Characterizing patient-reported outcomes in veterans with cirrhosis
por: Rogal, Shari S., et al.
Publicado: (2020)

Burden of Cirrhosis on Patients and Caregivers
por: Volk, Michael L.
Publicado: (2020)

Causal Mediation of Stress Reduction in Family Dementia Caregivers: A Focus on Mindfulness
por: Gomez, Liliana Ramirez, et al.
Publicado: (2021)

Inclusion of Sarcopenia Within MELD (MELD-Sarcopenia) and the Prediction of Mortality in Patients With Cirrhosis
por: Montano-Loza, Aldo J, et al.
Publicado: (2015)

A pilot study of a longitudinal mindfulness curriculum in undergraduate medical education
por: MacLean, Heather, et al.
Publicado: (2020)

Tu1264: PATIENTS WITH CIRRHOSIS EXPERIENCE HIGHER ICU MORTALITY COMPARED TO NON-CIRRHOTIC PATIENTS WHICH CONTINUED WITH OR WITHOUT COVID-19 DESPITE CONTROLLING FOR ORGAN FAILURE SEVERITY
por: Park, Dan, et al.
Publicado: (2022)

The Use of Rifaximin in Patients With Cirrhosis
por: Caraceni, Paolo, et al.
Publicado: (2021)

Cirrhosis is Associated with an Increased 30-Day Mortality After Venous Thromboembolism
por: Søgaard, Kirstine Kobberøe, et al.
Publicado: (2015)

Adventures in Developing an App for Covert Hepatic Encephalopathy
por: Bajaj, Jasmohan S
Publicado: (2017)

MINDFULNESS AND CAREGIVING EXPERIENCE IN ADRD CAREGIVERS
por: Tolea, Magdalena, et al.
Publicado: (2022)

A pilot study on mindfulness based stress reduction for smokers
por: Davis, James M, et al.
Publicado: (2007)

Development and Validation of a Symptom Scale Specific for Ascites Accompanied with Cirrhosis: The ASI-7
por: Onishi, Yoshihiro, et al.
Publicado: (2014)

No Rise in Incidence but Geographical Heterogeneity in the Occurrence of Primary Biliary Cirrhosis in North East England
por: McNally, Richard J. Q., et al.
Publicado: (2014)

Increased risk of venous thromboembolism in hospitalized patients with cirrhosis due to non-alcoholic steatohepatitis
por: Stine, Jonathan G., et al.
Publicado: (2018)

SACRED: Effect of simvastatin on hepatic decompensation and death in subjects with high-risk compensated cirrhosis: Statins and Cirrhosis: Reducing Events of Decompensation
por: Kaplan, David E., et al.
Publicado: (2021)

MIND diet lowers risk of open-angle glaucoma: the Rotterdam Study
por: Vergroesen, Joëlle E., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f7ljcqecole08spadcfjifajc3